𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multiple recurrences of acute tumor lysis syndrome in an indolent non-hodgkin's lymphoma

✍ Scribed by Ralph V. Boccia; Dan L. Longo; Michael L. Lieber; Elaine S. Jaffe; Richard I. Fisher


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
367 KB
Volume
56
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Tumor lysis syndrome occurring after the
✍ Yang, Honghao; Rosove, Michael H.; Figlin, Robert A. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 27 KB πŸ‘ 1 views

Rituximab, an anti-CD20 antibody, has been recently approved for the treatment of lowgrade or follicular non-Hodgkin's lymphoma (NHL). Because of its relatively benign side effect profile, it has been considered a nontoxic alternative to chemotherapy. Recently, however, tumor lysis syndrome (TLS) re

Acute tumor lysis syndrome in high grade
✍ Levin, Mark; Cho, Susan πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 217 KB πŸ‘ 1 views

Acute tumor lysis syndrome occurs in occurring after a sustained episode of high rapidly growing lymphoid malignancies, fever of 42.0" C in a patient with high grade usually as a consequence of chemotherapy lymphoblastic lymphoma and a high tumor or corticosteroids. We present what appears burden. Q

Competitive polymerase chain reaction to
✍ Marc Debled; Isabelle Hostein; ThΓ©rΓ¨se Astier-Gin; Houchingue Eghbali; FranΓ§oise πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 115 KB πŸ‘ 1 views

Detection of residual disease in follicular lymphoma is hampered by the observation of t(14;18)-bearing cells in the blood of healthy adult humans. To overcome this problem, we decided to validate a quantification method of t(14;18)bearing cells and test it in t(14;18)-bearing follicular lymphomas (